Blood Flow Restriction Therapy in Achilles Injury

Description

Blood flow restriction (BFR) therapy is a brief and partial restriction of venous outflow of an extremity during low load resistance exercises. It is a safe and effective method of improving strength in healthy and active individuals, recovering from orthopedic pathologies and procedures. This prospective, randomized study will look at the implications this form of treatment has on the rehabilitation of Achilles injuries.

Conditions

Achilles Injuries Tendon

Study Overview

Study Details

Study overview

Blood flow restriction (BFR) therapy is a brief and partial restriction of venous outflow of an extremity during low load resistance exercises. It is a safe and effective method of improving strength in healthy and active individuals, recovering from orthopedic pathologies and procedures. This prospective, randomized study will look at the implications this form of treatment has on the rehabilitation of Achilles injuries.

Blood Flow Restriction Therapy in Achilles Injury

Blood Flow Restriction Therapy in Achilles Injury

Condition
Achilles Injuries Tendon
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10017

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosed with Achilles Injury
  • * Must be at least 18 years of age and younger than 65 years of age
  • * Intention to receive physical therapy as standard of care
  • * Patients with intention to receive standard therapy and not the study therapy
  • * Patients with impaired circulation, peripheral vascular compromise, previous revascularization of the extremity, or severe hypertension
  • * Younger than 18 years of age or older than 65
  • * Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
  • * Any patient considered a vulnerable subject

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Guillem Gonzalez-Lomas, MD, PRINCIPAL_INVESTIGATOR, New York Langone Health

Study Record Dates

2025-04